S1a). and contending with CDK4 mRNA for binding miR-140-5p in the cytoplasm. Using bioinformatics analyses, we discovered hepatocarcinogenesis is specially connected with dysregulated appearance of SNHG1 and activation of the cell cycle pathway. SNHG1 was upregulated in HCC tissues and cells, and its knockdown significantly inhibited HCC cell cycle, CCG-63808 growth, metastasis, and epithelialCmesenchymal transition (EMT) both in vitro and in vivo. Chromatin immunoprecipitation and RNA immunoprecipitation assays demonstrate that SNHG1 inhibit the transcription of CDKN1A and CDKN2B through enhancing EZH2 mediated-H3K27me3 in the promoter of CDKN1A and CDKN2B, thus resulting in the de-repression of the cell cycle. Dual-luciferase assay and RNA pulldown revealed that SNHG1 promotes the expression of CDK4 by competitively binding to miR-140-5p. In conclusion, we propose that SNHG1 created a regulatory network to confer an oncogenic function in HCC and SNHG1 may serve as a potential target for HCC diagnosis and treatment. as a carcinogenic gene in HCC, which stimulates cell proliferation, promotes the course of cell cycle, and delays cell apoptosis6. These findings exhibited SNHG1 was involved in certain cancer progress, but the mechanisms were left to be further analyzed. MicroRNAs (miRNAs) are small, noncoding RNA transcripts with ~20 base pairs in length, which regulate miscellaneous biological activities by combining with target gene on posttranscriptional stage. Recent studies suggested that miRNAs were associated with malignancy progression. For example, miR-122 was found to be downregulated in HCC tissues and enhancing miR-122 expression in HCC with or without antitumor brokers could be feasibly applied to future HCC treatment strategy7. In addition, a study revealed that miR-140-5p targeting Nrf2 and Sirt2 accelerated doxorubicin-induced cardiotoxicity through encouraging oxidative stress in the heart8. Furthermore, another study reported that miR-140-5p was downregulated in breast malignancy, including both main tumor and cases with metastasis. In the mean time, the angiogenesis and invasion of breast malignancy was inhibited by exogenous expression of miR-140-5p through targeting vascular endothelial growth factor A9. Cell cycle is usually a particularly necessary progress for the growth and development of organisms. The cell cycle of eukaryote comprises M phase and interphase, and the interphase consist of G1, S, and G2 phases10. Before initiating DNA replicating process, cells in G1 can enter a resting state called G0 and then stop dividing. In addition, the cell cycle control system composed of a complex network of regulatory proteins, e.g., the cyclin-dependent kinases (CDKs) participates in regulating the cell cycle progression. CDK2/4/6 controls the checkpoint progression from G1 to S phase in cell cycle. Binding of their activated subunits, the E- or A-type cyclins for CCG-63808 CDK2 and the D-type cyclins for CDK4/6, prospects to retinoblastoma protein (Rb) phosphorylation and promotes the progression of cell cycle into S phase10. Another research suggested that inhibiting CDK4/6 expression arrested epithelial cell cycle and alleviated acute kidney injury11, which indicated CDK4/6 played a crucial role in cell proliferation. A clinical research found 73% CCG-63808 HCC samples experienced upregulated the expression of CDK4 protein, whereas 66% experienced downregulated the expression of cyclin D1 protein12. Therefore, CDK4 could be regarded as a clinical prognostic marker for HCC progression and it could be inferred that expressions of CDK4 were essential for certain cancer progress. In current study, lncRNAs and mRNAs with different B2M expression levels were screened out in HCC based on microarray analysis. Differentially expressed SNHG1, and SNHG1 were upregulated in HCC group in comparison with the control group. Open in a separate windows Fig. 1 Dysregulated mRNAs, lncRNAs, and signaling pathways in HCC were recognized.a Heatmap of top 20 differentially expressed mRNAs in HCC based on “type”:”entrez-geo”,”attrs”:”text”:”GSE115018″,”term_id”:”115018″GSE115018. was upregulated in HCC. b Heatmap of top 30 differentially expressed lncRNAs CCG-63808 in HCC based on “type”:”entrez-geo”,”attrs”:”text”:”GSE115018″,”term_id”:”115018″GSE115018. SNHG1 was upregulated in HCC. Differential expression analysis was performed with as one of them was upregulated in HCC. e Co-expression network between differentially expressed lncRNAs and mRNAs was visualized by Cytoscape.